An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis

References

• Adamson C D, Wildemann B, Sasaki M, Glass J D, McArthur J C, Christov V I, Dawson T M, Dawson V L. Immunologic NO synthetase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274: 1917–1921
   PubMed Web of Science ®Google Scholar
• Anders K H, Guerra W F, Tomiyasu U, Verity M A, Vinters H V. The neuropathology of AIDS: UCLA experience and review. Am J Pathol 1986; 124: 537–558
   PubMed Web of Science ®Google Scholar
• Brew B J, Rosenblum M, Cronin K, Price R W. AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Ann Neurol 1995; 38: 563–570
   PubMed Web of Science ®Google Scholar
• Budkn H. Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1986; 69: 253–258
   Google Scholar
• Bukrinsky M, Nottet H SLM, Schmidtmayerova H, Dubrovsky L, Flanagan C R, Mullins M E, Lipton S A, Gendelman H E. Regulationofnitricoxidesynthaseactivity inhuman immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HJV-associated neurological disease. J Exp Med 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Chao C C, Hu S, Close K, Choi C S, Molitor T W, Novick W J, Peterson PK. Cytokine release by microglia: Differential inhibition by pentoxifylllin and dexamethasone. J Inf Dis. 1992; 166: 847–853
   PubMed Web of Science ®Google Scholar
• Dawson V L, Dawson T M, Uhl G R, Snyder S H. Human immunodeficiency virus-1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256–3259
   PubMed Web of Science ®Google Scholar
• Gelbard H A, Nottet H SLM, Swindells S, Jett M, Dzenko K A, Genis P, White R, Wang L, Choi Y-B, Zhang D, Lipton S A, Tourtellotte W W, Epstein L G, Gendelman H E. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994; 68: 4628–4635
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Orenstein J M, Martin M A, Ferruca C, Mitra R, Phipps T, Wahl L A, Lane H C, Fauci S D, Burke D S, Skillman D R, Meltzer M S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988; 167: 1498–1506
   Google Scholar
• Gendelman H E, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R. The neuropathogenesis of HIV-1 dementia. AIDS 1997; 1: S35–45, (suppl. A)
   Google Scholar
• Genis P, Jett M, Bernton E W, Boyle T, Gelbard H A, Dzenko K, Keane R W, Resnick L, Mizrachi Y, Volsky D J, Epstein L G, Gendelman H E. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interations: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718
   Google Scholar
• Giulian D, Wendt E, Vaca K, Noonan C A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993; 90: 2769–2773
   PubMedGoogle Scholar
• Glass J D, Wesselingh S L, Seines O A, McArthur J C. Clinical and neuropathologic correlation with HIV-associated dementia. Ann Neurol 1993; 33: 2230–2237
   Google Scholar
• Griffin D E, Wesselingh S L, McArthur J C. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994; 35: 592–599
   PubMed Web of Science ®Google Scholar
• Kalter D C, Nakamura M, Turpin J A, Baca L M, Dieffenbach C, Ralph P, Gendelman H E, Meltzer M S. Enhanced HIV replication in MCSF-treated monocytes. J Immunol 1991; 146: 298–307
   PubMedGoogle Scholar
• Kieburtz K, Schiffer R B. Neurological manifestations of human immunodeficiency virus infections. Neurol Clin 1989; 7: 447–468
   Google Scholar
• Koenig S, Gendelman H E, Orenstein J M, Dal Canto M C, Pezeshkpour G H, Yungbluth M, Janotta F, Aksamit A, Martin M A, Fauci A S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233: 1089–1093
   PubMed Web of Science ®Google Scholar
• Koka P, He K, Zack J A, Kitchen S, Peacock W, Fried I, Tran T, Yashar S S, Marrill J E. Human immunodeficiency virus 1 envelope proteins induce interleukin-1, tumor necrosis factor-x, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J Exp Med 1995; 182: 941–952
   PubMed Web of Science ®Google Scholar
• Korber B TM, Kunstman K J, Patterson B K, Furtado M, McEvilly M M, Levy R, Wolinsky S M. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type-1 infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68: 7467–7481
   PubMed Web of Science ®Google Scholar
• Lipton S A. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 1992; 3: 913–915
   PubMed Web of Science ®Google Scholar
• Lipton S A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci 1994; 16: 145–151
   Google Scholar
• Lipton S A, Rosenberg R A. Mechanisms of disease: Excitatory animo acids as final common pathway for neurological disorders. N Engl J Med 1994; 330: 613–622
   PubMed Web of Science ®Google Scholar
• Lipton S A, Gendelman H E. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332: 934–940
   PubMed Web of Science ®Google Scholar
• Masliah E, Achim C L, Ge N, DeTeresa R, Terry R D, Wiley C A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992a; 32: 321–329
   PubMed Web of Science ®Google Scholar
• Masliah Ge E. N., Achim C L, Hansen L A, Wiley C A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992b; 51: 585–593
   Google Scholar
• Merrill J E, Martinez-Maza O. Cytokines in AIDS associated neurons and immune dysfunction. Neurobiology of Cytokines. Methods in Neuroscience, EB De Zouza. Academic Press, San Diego 1993; 243–249
   Google Scholar
• Mucke L., Masliah E, Campbell I L. Transgenic animal models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr Top Microbiol Immunol 1995; 202: 187–205
   Google Scholar
• Navia M A, Jordan B D, Price R W. The AIDS dementia complex. II. Clinical features. Ann Neurol 1986a; 19: 517–524
   PubMed Web of Science ®Google Scholar
• Navia B A, Cho E-S, Petito C K, Price R W. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986b; 19: 525–535
   PubMed Web of Science ®Google Scholar
• Nottelt H SLM, Jett M, Flanagan C R, Zhai Q-H, Persidsky Y, Rizzino A, Bernton E W, Genis P, Baldwin T, Schwartz J, LaBenz C J, Gendelman H E. A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995; 154: 3567–3581
   Google Scholar
• Parisi A, Stossoll M, Pan A, Maserati R, Minoli L. HIV-related encephalitis presenting as convulsant disease. Clin Electroenceph 1991; 22: 1–4
   Google Scholar
• Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet H SM, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello S J, Gendelman H E. Neuropathological analysis of HIV encephalitis in SCID mice. Am J Pathol 1990; 149: 1027–1053
   Google Scholar
• Peterson P K, Gekker G, Hu S, Schoolov Y, Balfour H H, Chao C C. Microglial cells upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: The role of tumor necrosis factor-α. J Neuroimmunol 1992; 14: 81–88
   Google Scholar
• Petilo C K, Cho E-S, Lemann W, Navia B A, Price R W. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986; 45: 635–646
   Google Scholar
• Piani D, Spranger M, Frei K, Schaffner A, Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-Aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992; 22: 2429–2436
   PubMed Web of Science ®Google Scholar
• Poli C, Kinter A, Justement J S. Tumor necrosis factor-a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990; 87: 782–785
   PubMed Web of Science ®Google Scholar
• Power C, McArthur J C, Johnson R T, Griffin D E, Glass J D, Ferryman S, Chesebro B. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68: 4043–4649
   Google Scholar
• Price R W, Brew B, Sidhs J, Rosenblum M, Shock A C, Cleary P. The brain in AIDS: CNS HIV-1 infection and AIDS dementia complex. Science 1988a; 239: 580–592
   Google Scholar
• Price R W, Sidtis J, Rosenblum M. The AIDS dementia complex: some current questions. Ann Neurol 1988b; 23: S27–S33
   PubMed Web of Science ®Google Scholar
• Sharer L R, Cho E S, Epstein L C. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985; 16: 700
   Google Scholar
• Toggas S M, Masliah E, Rockonstein E M, Rall G F, Abraham C R, Mucke L. Central nervous system damage produced by expression of the HIV 1 coal protein gp120 in transgenic mice. Nature 1994; 307: 188–193
   Google Scholar
• Toggas S M, Masliah E, Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1990; 706: 303–307
   Google Scholar
• Tyor W R, Glass J D, Griffin J W, Becker P S, McArthur J C, Bezman L, Griffin D E. Cytokine expression in the brain during the acquired immunodeficiency disease syndrome. Ann Neurol 1992; 31: 349–300
   PubMed Web of Science ®Google Scholar
• Wahl L M, Corcoran M L, Pyle S W, Arthur LO, Harel Bellan A, Farrar W L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin-1. Proc Natl Acad Sci USA 1989; 86: 621–625
   PubMed Web of Science ®Google Scholar
• Weeks B S, Lieberman D M, Johnson B. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the 1 lal amino acid 49–58 basic domain. J Neurose Res 1995; 42: 34–40
   PubMed Web of Science ®Google Scholar
• Wesselingh S L, Power G, Glass J D, Tylor W R, McArthur J C, Farber J M, Griffin J W, Griffin D E. Intracerebral cytokine mRNA expression in AIDS. Ann Neurol 1993; 33: 576–582
   PubMedGoogle Scholar
• Wiley C A, Schrier R D, Nelson J A, Lampert P W, Oldstone M BA. Cellular localization of human immunodeficiency virus infection within brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089–7093
   PubMed Web of Science ®Google Scholar
• Wiley C A, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency disease syndrome. Ann Neurol 1994; 36: 073–670
   Google Scholar
• Wyss-Coray T, Masliah E, Toggas S. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic: mice and humans with HIV-1 encephalitis. J Clin Invest 1996; 97: 789–798
   Google Scholar